Ibogaine Treatment for Suboxone Addiction
Suboxone (a combination of buprenorphine and naloxone) was developed as a “harm reduction” medication to help patients transition away from short-acting opioids like heroin and oxycodone. By partially activating the brain’s opioid receptors, it prevents acute withdrawal and reduces cravings.
However, Suboxone presents a severe, secondary challenge: buprenorphine has a profoundly long half-life and binds to opioid receptors more tightly than almost any other opiate. While it stabilizes the user’s life, trying to taper off Suboxone entirely often results in a grueling, protracted withdrawal process that can last for 30 to 60 days. The bone aches, severe depression, lethargy, and insomnia drive many individuals right back to the medication.
Standard detox facilities are notoriously ill-equipped to handle Suboxone withdrawal. At Ibogaine By David Dardashti, we utilize a specialized, extended 9-to-12-day ibogaine protocol designed specifically to strip long-acting opiates from the receptors, deeply flush the system, and bypass weeks of agony.
The 9-12 Day Suboxone Protocol
Because buprenorphine is deeply stored in the body and slowly released over time, a standard opioid detox timeline is insufficient. Our medical team uses a precise, multi-dose approach over 9 to 12 days to ensure the buprenorphine is completely cleared from your system.
1. Stabilization and The Transition Bridge (Days 1-2)
You cannot simply take ibogaine while Suboxone is still active in your system, as the buprenorphine will block the ibogaine from fully accessing and resetting your opioid receptors. Upon arrival, you will undergo full EKG and blood testing. Under strict medical supervision, you will be temporarily transitioned to a Short-Acting Opiate (SAO). This “bridge” allows the long-acting buprenorphine to leave your receptors while keeping you comfortable and withdrawal-free until you are ready for ibogaine.
2. Three Specialized Flood Doses
Suboxone’s tight receptor binding requires repeated, profound neurochemical resets. Instead of one or two doses, our protocol utilizes three flood doses spaced strategically throughout your stay:
-
Dose 1: The initial reset. This dose aggressively targets the receptors, flushing out the short-acting bridge medications and the remaining buprenorphine, stopping the acute withdrawal process in its tracks.
-
Dose 2: Administered a few days later, this dose targets residual physical symptoms and begins the deep psychological work, modulating the NMDA receptors to address the underlying trauma of addiction.
-
Dose 3: The final sweep. This dose ensures the receptors are completely clean and resets the serotonin pathways to combat the severe depression typically associated with buprenorphine cessation.
3. 3-4 Booster Treatments
To manage any lingering post-acute withdrawal symptoms (PAWS) and elevate your baseline mood, our medical staff will administer three to four targeted booster doses on your non-flood days. These boosters convert to noribogaine in the liver, storing in your fat cells to provide a sustained, natural antidepressant effect and energy boost that lasts for months.
Integration: Rebuilding Your Mind and Body
The intensity of a 9-to-12-day Suboxone detox requires an equally powerful environment for rest and recovery. The days between your flood doses are dedicated entirely to processing your experience and allowing your nervous system to heal.
At our Playa del Carmen clinic, your clinical treatment is paired with a holistic integration program:
-
Psychotherapy: Daily sessions with our specialized therapists to help you process the visionary aspects of your flood doses and map out your new, substance-free life.
-
Cenote Excursions: Guided trips to swim in the ancient, mineral-rich waters of local Mayan cenotes, which physically cool the body and calm the central nervous system.
-
Beach Trips: Time spent grounding yourself on the Caribbean coast to reconnect with nature.
-
Mayan Ruins: Guided, low-stress cultural visits to historic ruins to inspire awe and a renewed perspective on life.
-
Yoga and Somatic Healing: Gentle, restorative yoga designed to ease muscle tension, stretch the body, and release trauma stored in the physical tissues.
Peer-Reviewed Efficacy: Ibogaine and Long-Acting Opioids
Treating Suboxone and methadone dependence is widely considered one of the hardest challenges in addiction medicine. However, peer-reviewed clinical research highlights ibogaine’s unique efficacy in this area.
-
Receptor Resetting: Research published in The American Journal on Addictions notes that ibogaine effectively attenuates opioid withdrawal by binding to multiple sites (including kappa-opioid and NMDA receptors) simultaneously. This broad-spectrum binding is what allows it to dislodge stubborn buprenorphine molecules where traditional tapering fails.
-
PAWS Mitigation: A study in the Journal of Psychopharmacology observed that the long-acting metabolite noribogaine plays a critical role in preventing Post-Acute Withdrawal Syndrome (PAWS). For Suboxone patients—who typically face months of PAWS—the slow release of noribogaine significantly reduces the depression and lethargy that trigger relapse.
-
Sustained Abstinence: Observational data from MAPS (Multidisciplinary Association for Psychedelic Studies) indicates that patients transitioning from long-acting opioids to ibogaine via an SAO bridge experience significantly higher rates of long-term abstinence compared to standard tapering programs.